Member Info for twib

From the 12 March RNS:

Ronjon Nag, comments "I am so pleased to join the Board of capAI, with the aim of developing a public entity to access next level advancements in AI and deep science developed by myself and others."

Babybel traded this last week for profit. He's trying to do the same again, and gain an advantageous entry price.

DYOR IMHO GLA FFS PFO

It's not an acquisition that they are targeting. One of Prof Nag's companies - hopefully Healx https://healx.ai/ - will RTO into capAI. They are close to bringing product to market and will need increased capital and liquidity.

Has anyone had a serious look at Healx? It has an enterprise value of $188m - $282m. Let that sink in.

https://healx.ai/healx-announces-first-patient-dosed-in-phase-2-trial-evaluating-hlx-1502-for-the-treatment-of-neurofibromatosis-type-1/

Don't let Babybel fool you folks.

DYOR IMHO GLA FFS PFO

Don't let Sharebell tell you otherwise.

He reramped last week to get an entry and traded the living daylights out of it. He's up to the same again. Sit on your hands. Don't give them the opportunity. Sleaze.

IMHO DYOR GLA FFS PFO

Need to break 0.17p on the short term chart, clear the 0.27p area, and then it's a march to 0.65p.

News expected between now and AGM on 31 March

If you want to know what Prof Nag is about, check out Healx, the board of which he is on and R42 Group has invested in the latest funding round.

Then you can sit back and relax and wait for the news to roll in, in the knowledge we have an unbelievable director on board (not a NED, but an Executive Director, which speaks volumes).

Not AIM pal

What will the placing be for?

They've dropped the bid to fish for shares

0.17 is proving to be resistance at the moment. Once broken, that will form the new support.

Someone loading up in 5m tranches. Almost like the SP is being held down for them.

As nice a thought as that is Lesh, he clearly wants a publicly-listed, main market vehicle. He is bringing something to market - whether that be the AI cancer diagnosis and treatment methods, or the anti-aging technology - and knows there will be huge interest, and those who want to be part of the journey and invest with him. Whatever he is bringing is bigger than his Family Office/private equity setup, and he will want institutional investors on board.

Thanks for the sage advice Flightman

I’m holding 49.5m at avg 0.042. Very hard not to top-slice. I have full faith in Prof Nag.

Que?

The real price target this week is 0.24-0.27p.

Who knew Sharebell was smarter than Professor Nag?

IMHO DYOR GLA FFS PFO

In August 2024, Healx, a Cambridge-based AI-driven biotech firm specializing in rare diseases, secured $47 million in a Series C funding round. This round was co-led by R42 Group and Atomico, with participation from investors such as Balderton, Jonathan Milner, Global Brain, btov, Ayana Capital, o2h, and VU Venture Partners.  

The capital injection aims to advance Healx’s pipeline, notably progressing HLX-1502 into a Phase 2 clinical trial for neurofibromatosis Type 1 (NF1). The U.S. FDA has cleared the investigational new drug application for HLX-1502, with the Phase 2 trial expected to commence by the end of 2024. 

Co-founded by Dr. David Brown, co-inventor of Viagra, and CEO Dr. Tim Guilliams, Healx integrates generative AI technology with drug discovery expertise to expedite treatments for rare diseases. The company has raised approximately $110 million to date.  

As part of the funding round, Dr. Ronjon Nag, founder of R42 Group and a 2024 Silicon Valley Hall of Fame AI inductee, joined Healx’s board.